2004
DOI: 10.1111/j.1600-0609.2004.00213.x
|View full text |Cite
|
Sign up to set email alerts
|

Rupture of chordae tendineae in patients with β‐thalassemia

Abstract: Cardiac disease is the primary cause of mortality in beta-thalassemia patients. Except for ventricular dysfunction and pulmonary hypertension that represent the main forms of heart disease in these patients, valvular abnormalities including valvular regurgitation, endocardial thickening and calcification and mitral valve prolapse have also been described. Here we present two patients with thalassemia major and mitral chordal rupture, a previously undescribed abnormality in this population. Pathogenesis of this… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 19 publications
0
5
0
Order By: Relevance
“…These cardiac complications in regularly transfused patients are a culmination of two factors: (i) the human body has a limited ability to excrete excess iron (Fassos et al , 1996; Hershko et al , 2005) and (ii) iron deposits in the heart are detectable when the liver and spleen iron stores are already full and are thus indicative of advanced disease (Johnston et al , 1989). The cardiovascular effects of the myocardial iron deposits are extensive and include endothelial dysfunction (Gaenzer et al , 2002), increased heart wall thickness (Aessopos et al , 2004), atherosclerosis (Meyers, 2000), valvular diseases (Farmakis et al , 2004; Wu et al , 2004), coronary artery disease (Sonakul et al , 1988; Mariotti et al , 1993; Hahalis et al , 2005), heart failure (Kremastinos et al , 2001; Schwartz et al , 2002; Hahalis et al , 2005), arrhythmias (Kucukosmanoglu et al , 2002; Borgna‐Pignatti et al , 2004) pulmonary artery hypertension (Aessopos et al , 2007) and disturbed lipid metabolism (Al‐Quobaili & Abou Asali, 2004; Chrysohoou et al , 2004).…”
mentioning
confidence: 99%
“…These cardiac complications in regularly transfused patients are a culmination of two factors: (i) the human body has a limited ability to excrete excess iron (Fassos et al , 1996; Hershko et al , 2005) and (ii) iron deposits in the heart are detectable when the liver and spleen iron stores are already full and are thus indicative of advanced disease (Johnston et al , 1989). The cardiovascular effects of the myocardial iron deposits are extensive and include endothelial dysfunction (Gaenzer et al , 2002), increased heart wall thickness (Aessopos et al , 2004), atherosclerosis (Meyers, 2000), valvular diseases (Farmakis et al , 2004; Wu et al , 2004), coronary artery disease (Sonakul et al , 1988; Mariotti et al , 1993; Hahalis et al , 2005), heart failure (Kremastinos et al , 2001; Schwartz et al , 2002; Hahalis et al , 2005), arrhythmias (Kucukosmanoglu et al , 2002; Borgna‐Pignatti et al , 2004) pulmonary artery hypertension (Aessopos et al , 2007) and disturbed lipid metabolism (Al‐Quobaili & Abou Asali, 2004; Chrysohoou et al , 2004).…”
mentioning
confidence: 99%
“…Mitral valve prolapse is another well‐described association . There have also been reports of rupture of chordae tendinae with mitral regurgitation . We had two patients with mitral regurgitation in our group, one of whom had rupture of chordae tendinae confirmed at surgery (Fig.…”
Section: Cardiovascular Systemmentioning
confidence: 93%
“…Cardiac complications rank among the leading causes of death in BTM. Left ventricular dysfunction and cardiac failure, resulting primarily from iron overload, is a major feature of BTM whereas pulmonary hypertension and right ventricular failure seem more common in beta thalassaemia intermedia …”
Section: Cardiovascular Systemmentioning
confidence: 99%
See 2 more Smart Citations